GO:0008650 rRNA (uridine-2'-O-ribose)-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008650 describes the enzymatic activity that transfers a methyl group from S-adenosyl-L-methionine to the 2'-O position of a uridine in ribosomal RNA, producing 2'-O-methyluridine and S-adenosyl-L-homocysteine.
• This modification is part of the broader family of RNA 2'-O-methylations that influence ribosome structure, stability, and translation fidelity.
• The reaction is catalyzed by methyltransferase enzymes that often use a Rossmann-like fold and a catalytic tetrad to deprotonate the ribose hydroxyl.
• Dysregulation of rRNA methylation has been linked to cancer, developmental disorders, and ribosomopathies, making these enzymes potential therapeutic targets.
• Key experimental approaches include CRISPR knockout and point-mutation models, Ribo-seq, RNA-seq, and mass spectrometry-based modification mapping.
• EDITGENE provides validated CRISPR cell models and screening services to study GO:0008650-related genes in disease and development.
Description
GO:0008650, rRNA (uridine-2'-O-ribose)-methyltransferase activity, is a molecular function that catalyzes the methylation of the 2'-O position of uridine in ribosomal RNA using S-adenosyl-L-methionine as the methyl donor. This modification is one of the most abundant RNA modifications and is critical for ribosome biogenesis and function. Researchers study this activity to understand how post-transcriptional modifications shape translation and how their dysregulation contributes to disease. The reaction produces 2'-O-methyluridine and S-adenosyl-L-homocysteine, and it is carried out by enzymes that often share structural features with other Rossmann-fold methyltransferases. Because rRNA modifications are essential for ribosome assembly and stability, perturbations in this activity can have broad effects on cellular proteostasis and growth. In this article, we provide a comprehensive overview of GO:0008650, including its definition, mechanism, key genes, disease relevance, and experimental methods for studying it.
rRNA (uridine-2'-O-ribose)-methyltransferase activity At A Glance
| GO ID | GO:0008650 |
|---|---|
| GO term | rRNA (uridine-2'-O-ribose)-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | rRNA (uridine-2'-O-)-methyltransferase activity |
| Definition | Catalysis of the reaction: a uridine in rRNA + S-adenosyl-L-methionine = a 2'-O-methyluridine in rRNA + S-adenosyl-L-homocysteine + H+. |
| Major function | 2'-O-methylation of uridine in ribosomal RNA |
| Cofactor | S-adenosyl-L-methionine (SAM) |
| Product | 2'-O-methyluridine in rRNA and S-adenosyl-L-homocysteine |
| Related activity | rRNA methyltransferase activity, RNA 2'-O-methyltransferase activity |
What Is GO:0008650?
According to the Gene Ontology, GO:0008650 is defined as the catalysis of the reaction: a uridine in rRNA + S-adenosyl-L-methionine = a 2'-O-methyluridine in rRNA + S-adenosyl-L-homocysteine + H+. In simpler terms, it is the enzyme activity that adds a methyl group to the 2'-oxygen of a uridine nucleotide within ribosomal RNA, using SAM as the methyl donor. This modification is part of the 2'-O-methylation landscape of RNA and is distinct from base methylations such as m6A or m5C.
Why Is rRNA (uridine-2'-O-ribose)-methyltransferase activity Important in Cell Biology?
GO:0008650 is important because 2'-O-methylation of rRNA is a conserved and essential modification that affects ribosome structure, stability, and translational fidelity. Enzymes that catalyze this reaction are often conserved from bacteria to humans, and their dysfunction has been implicated in cancer, developmental defects, and ribosomopathies. Understanding this activity provides insights into basic RNA biology and offers potential targets for therapeutic intervention.
• rRNA 2'-O-methylation is critical for ribosome assembly and function.
• The modification can influence translation initiation, elongation, and fidelity.
• Dysregulation of rRNA methyltransferases is observed in various cancers.
• Mutations in rRNA modification enzymes are linked to inherited bone marrow failure and developmental disorders.
• Small-molecule inhibitors targeting methyltransferases are being explored as anticancer agents.
• CRISPR-based models enable functional dissection of these enzymes in disease contexts.
• Ribo-seq and mass spectrometry allow mapping of modification sites and translation effects.
• The activity is a potential biomarker for cancer diagnosis and prognosis.
What Happens During rRNA (uridine-2'-O-ribose)-methyltransferase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds the specific uridine in rRNA and holds it in place.
The methyltransferase enzyme recognizes a specific uridine residue within the ribosomal RNA, often guided by secondary structure elements or accessory proteins. Structural studies of related methyltransferases show that they use a Rossmann-like fold to bind the methyl donor S-adenosyl-L-methionine and a catalytic domain to position the target nucleotide. The enzyme may also interact with other ribosome assembly factors to ensure correct timing and site specificity.
Methyl Group Transfer
In simple terms: The enzyme transfers a methyl group from SAM to the 2'-oxygen of the uridine.
Once the substrate is bound, the enzyme catalyzes the transfer of the methyl group from S-adenosyl-L-methionine to the 2'-hydroxyl of the uridine, forming 2'-O-methyluridine and S-adenosyl-L-homocysteine. This reaction typically involves a catalytic tetrad of amino acids that deprotonates the ribose hydroxyl to facilitate nucleophilic attack. The reaction is highly specific for the 2'-O position and does not modify other nucleotides.
Product Release and Ribosome Assembly
In simple terms: After methylation, the modified rRNA is released and incorporated into the ribosome.
Following methyl transfer, the enzyme releases the modified rRNA and S-adenosyl-L-homocysteine. The 2'-O-methyluridine modification can affect local RNA structure and stability, influencing subsequent steps in ribosome assembly and maturation. In eukaryotic cells, this process occurs largely in the nucleolus and is coordinated with other rRNA processing events.
Regulation and Quality Control
In simple terms: Cells monitor and regulate this modification to ensure proper ribosome function.
The activity of rRNA methyltransferases can be regulated at multiple levels, including expression levels, post-translational modifications, and interaction with assembly factors. Quality control pathways ensure that only correctly modified and assembled ribosomes are exported to the cytoplasm. Dysregulation of these processes can lead to ribosome heterogeneity and disease.
Key Genes Involved in GO:0008650 rRNA (uridine-2'-O-ribose)-methyltransferase activity
The following genes encode enzymes or associated factors that carry out or regulate rRNA (uridine-2'-O-ribose)-methyltransferase activity or related rRNA modifications.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FBL | Catalyzes 2'-O-methylation of rRNA | Key enzyme for rRNA modification; studied in cancer and ribosomopathies |
| DIMT1 | rRNA methyltransferase, generates dimethylation | Involved in small RNA modification; potential cancer target |
| METTL16 | m6A methyltransferase with rRNA-related functions | Regulates RNA modification and translation; linked to cancer |
| NSUN2 | m5C RNA methyltransferase | Affects rRNA and tRNA modification; role in stem cells and cancer |
| NSUN4 | rRNA m5C methyltransferase | Mitochondrial ribosome assembly; disease associations |
| METTL3 | m6A methyltransferase | Not directly 2'-O but part of rRNA modification network |
| METTL14 | m6A methyltransferase | Interacts with METTL3; potential indirect role |
| WTAP | m6A methyltransferase complex component | Regulates RNA modification; cancer relevance |
| VIRMA | m6A methyltransferase complex component | Involved in RNA modification and cancer |
| ZC3H13 | m6A methyltransferase complex component | Regulates RNA methylation; developmental roles |
| RBM15 | m6A methyltransferase complex component | RNA modification and cancer |
| FTO | m6A demethylase | Erases RNA methylation; cancer and metabolism |
| ALKBH5 | m6A demethylase | RNA demethylation; cancer and stem cells |
| YTHDF1 | m6A reader | Recognizes methylated RNA; translation regulation |
| YTHDF2 | m6A reader | RNA stability; cancer |
| IGF2BP1 | m6A reader | RNA stability and translation; cancer |
| HNRNPA2B1 | m6A reader | RNA processing; cancer |
How Is rRNA (uridine-2'-O-ribose)-methyltransferase activity Regulated?
The activity of rRNA (uridine-2'-O-ribose)-methyltransferases is regulated at multiple levels. Expression of the enzymes can be controlled by transcription factors and signaling pathways such as mTOR, which promotes ribosome biogenesis. Post-translational modifications, including phosphorylation and ubiquitination, can modulate enzyme activity and stability. Additionally, the availability of S-adenosyl-L-methionine, the methyl donor, influences the rate of methylation. Interactions with other ribosome assembly factors and the structural context of the rRNA also regulate site-specific modification.
rRNA (uridine-2'-O-ribose)-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FBL | Cancer, ribosomopathy | CRISPR knockout in cancer cell lines; xenograft models |
| METTL16 | Cancer, metabolic disorders | Knockout and overexpression in hepatocytes; mouse models |
| DIMT1 | Cancer, developmental defects | Point mutation knock-in in stem cells; zebrafish |
| NSUN2 | Cancer, stem cell regulation | Conditional knockout in mouse models |
| NSUN4 | Mitochondrial ribosomopathy | Knockout in muscle cells; mitochondrial function assays |
Cancer
Dysregulation of rRNA methylation enzymes has been observed in multiple cancers. For example, FBL is overexpressed in several tumor types and is associated with poor prognosis. METTL16 and other methyltransferases are implicated in cancer biology and are being explored as therapeutic targets. Small-molecule inhibitors targeting these enzymes are under development.
Ribosomopathies and Developmental Disorders
Mutations in genes encoding ribosome assembly factors and rRNA modification enzymes can cause ribosomopathies, such as Diamond-Blackfan anemia and Shwachman-Diamond syndrome. These disorders often present with bone marrow failure and developmental abnormalities, highlighting the importance of proper rRNA modification for tissue-specific translation.
Neurological and Metabolic Disorders
Emerging evidence links RNA modifications to neurological and metabolic diseases. For instance, m6A modification enzymes are associated with obesity and neuronal function. While direct links to 2'-O-methylation are less established, the broader network of RNA methylation is likely to play a role.
From rRNA (uridine-2'-O-ribose)-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FBL affect rRNA methylation and translation? | CRISPR knockout of FBL in HEK293T cells followed by Ribo-seq |
| What is the catalytic mechanism of DIMT1? | Point mutation of catalytic residues followed by in vitro methylation assays |
| Can a disease-associated mutation in METTL16 be rescued? | Knock-in of mutant allele in patient-derived iPSCs |
| Where does NSUN2 localize in cells? | Tagged knock-in with GFP for live-cell imaging |
| Does overexpression of FBL promote tumor growth? | Overexpression in cancer cell lines and mouse xenografts |
| What are the off-target effects of methyltransferase inhibitors? | CRISPR library screening with drug treatment |
How to Study the rRNA (uridine-2'-O-ribose)-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Global translation profiling upon knockout |
| RiboMethSeq | 2'-O-methylation sites in rRNA | Mapping modification sites and enzyme specificity |
| Mass spectrometry | RNA modification stoichiometry | Quantifying 2'-O-methyluridine levels |
| CRISPR knockout | Gene function loss | Studying essentiality and phenotypes |
| CRISPR point mutation | Specific amino acid function | Dissecting catalytic residues |
| Knock-in tagging | Protein localization and interactions | Live-cell imaging and IP |
| Overexpression | Gain-of-function effects | Cancer models and drug resistance |
| CRISPR library screening | Genome-wide fitness | Identifying synthetic lethal interactions |
Ribo-seq and Translation Profiling
Ribo-seq provides a snapshot of ribosome occupancy on mRNAs, revealing changes in translation efficiency upon perturbation of rRNA methylation. This method can detect global translation defects and specific codon effects.
RNA Modification Mapping
Mass spectrometry and sequencing-based methods such as m6A-seq or 2'-O-methylation mapping (e.g., RiboMethSeq) allow site-specific detection of rRNA modifications. These techniques are essential for validating the activity of methyltransferases.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify protein interaction partners of rRNA methyltransferases, revealing assembly factors and regulatory proteins. Phosphoproteomics can uncover post-translational modifications that regulate enzyme activity.
Imaging and Cellular Localization
Fluorescence microscopy of tagged methyltransferases (e.g., GFP knock-in) allows visualization of their subcellular localization, particularly in the nucleolus. Live-cell imaging can track dynamics during ribosome assembly.
How CRISPR Can Be Used to Study GO:0008650 rRNA (uridine-2'-O-ribose)-methyltransferase activity
Knockout
CRISPR knockout of genes encoding rRNA methyltransferases (e.g., FBL, DIMT1) allows researchers to assess their essentiality and impact on ribosome function. Knockout cell lines can be used for Ribo-seq and proteomics to uncover downstream effects.
Point Mutation
Introducing point mutations in catalytic residues (e.g., in the Rossmann-fold or catalytic tetrad) can abolish methyltransferase activity without affecting protein stability, enabling separation of catalytic and non-catalytic functions.
Knock-in
Knock-in of disease-associated mutations or tagged versions (e.g., GFP) allows study of mutant enzymes in a physiological context. This is particularly useful for modeling ribosomopathies and cancer.
Overexpression
Overexpression of rRNA methyltransferases can mimic oncogenic states and test whether increased activity drives proliferation or drug resistance. Such models are valuable for preclinical drug testing.
How EDITGENE Supports rRNA (uridine-2'-O-ribose)-methyltransferase activity Research
Researchers studying rRNA (uridine-2'-O-ribose)-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in ribosome function, translation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for rRNA (uridine-2'-O-ribose)-methyltransferase activity research.
Frequently Asked Questions About rRNA (uridine-2'-O-ribose)-methyltransferase activity
What is GO:0008650?
GO:0008650 is the Gene Ontology term for rRNA (uridine-2'-O-ribose)-methyltransferase activity, which catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to the 2'-O position of uridine in ribosomal RNA.
What genes are involved in rRNA (uridine-2'-O-ribose)-methyltransferase activity?
Key genes include FBL, DIMT1, METTL16, and NSUN family members, which encode enzymes that modify rRNA or related RNA species.
What diseases are associated with rRNA methylation defects?
Dysregulation of rRNA methylation has been linked to cancers, ribosomopathies, and developmental disorders.
How can I study rRNA (uridine-2'-O-ribose)-methyltransferase activity?
Common methods include CRISPR knockout, Ribo-seq, mass spectrometry, and RNA modification mapping.
What is the role of FBL in rRNA methylation?
FBL is a conserved methyltransferase that catalyzes 2'-O-methylation of rRNA and is essential for ribosome biogenesis.
Is METTL16 involved in rRNA methylation?
METTL16 primarily methylates m6A in mRNA and non-coding RNA, but it may indirectly influence rRNA modification networks.
What are the potential therapeutic targets in this pathway?
Methyltransferases such as FBL and METTL16 are being explored as anticancer targets, with small-molecule inhibitors under development.
How does 2'-O-methylation affect translation?
2'-O-methylation can influence ribosome structure and stability, thereby affecting translation efficiency and fidelity.
Can CRISPR be used to model rRNA methylation diseases?
Yes, CRISPR knockout and knock-in models are widely used to study the functional consequences of mutations in rRNA methyltransferases.
What services does EDITGENE offer for studying this pathway?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services.
Conclusion
GO:0008650, rRNA (uridine-2'-O-ribose)-methyltransferase activity, represents a fundamental RNA modification that impacts ribosome function and cellular health. Understanding its mechanism, regulation, and disease relevance is crucial for developing new therapeutic strategies. EDITGENE's CRISPR-based models and screening services empower researchers to dissect this pathway with precision and efficiency.
References
- 1. Oerum S et al.. 2021. A comprehensive review of m6A/m6Am RNA methyltransferase structures.. Nucleic Acids Res 49(13):7239-7255 PMID: 34023900
- 2. Shen H et al.. 2021. Human DIMT1 generates N(2)(6,6)A-dimethylation-containing small RNAs.. J Biol Chem 297(4):101146 PMID: 34473991
- 3. Qi YN et al.. 2023. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.. J Hematol Oncol 16(1):89 PMID: 37533128
- 4. Ruszkowska A. 2021. METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function.. Int J Mol Sci 22(4) PMID: 33671635
- 5. Chang CH et al.. 2025. Nucleolar fibrillarin methyltransferase regulates systemic trafficking of a plant virus satellite RNA.. Plant Cell 37(10) PMID: 40982556
- 8. Moon J et al.. 2025. NSUN-Mediated m5C RNA Modification in Stem Cell Regulation.. Cells 14(20) PMID: 41148823
